Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epioxa and UV-A Irradiation for Keratoconus
NCT07629557Phase 4Recruiting
- Sponsor
- Glaukos Corporation
- Start
- May 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
A Phase 4 trial of olmesartan medoxomil + amlodipine in keratoconus, sponsored by Glaukos Corporation. Started May 2026; status: recruiting.
02
Drugs
olmesartan medoxomil + amlodipine
03
Conditions
keratoconus
Beyond the preview
Go deeper on NCT07629557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07629557.